✦ LIBER ✦

High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels

✍ Scribed by Kanfer, EJ; McGuigan, D; Samson, D; Abboudi, Z; Abrahamson, G; Apperley, JF; Chilcott, S; Craddock, C; Davis, J; MacDonald, C

Book ID: 109838630
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 748 KB
Volume: 78
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1998.603

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cyclophosphamide with or witho

High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity

✍ Gojo, I; Guo, C; Sarkodee-Adoo, C; Meisenberg, B; Fassas, A; Rapoport, A P; Cott 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Peripheral blood progenitor cell mobiliz

Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage–colony-stimulating factor and granulocyte–colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation

✍ Asad Bashey; Michael Donohue; Lin Liu; Bridget Medina; Sue Corringham; Anita Iha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Efficacy and toxicity of a high-dose G-C

Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors

✍ Martínez, C; Urbano-Ispizua, A; Marín, P; Merino, A; Rovira, M; Carreras, E; Mon 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

Ifosamide, epirubicin and granulocyte co

Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma

✍ M. Arland; S. Leuner; S. Lange; R. Bartsch; C. Kahl; A. Florschütz; A. Franke; H 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract In general, the mobilization of peripheral blood progenitor cells (PBPC) in multiple myeloma (MM) patients is poor and is achieved in most cases by combined cyclophosphamide and G‐CSF. This study was performed to examine the efficacy of combined ifosfamide/epirubicine and G‐CSF for PBPC

Release of peripheral blood progenitor c

Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy

✍ Marco Venturini; Lucia Del Mastro; Ornella Garrone; Riccardo Rosso; Giovanni Mel 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Background. High dose chemotherapy with the support of peripheral blood progenitor cells (PBPC) is increasingly used in the treatment of solid tumors. Although the best method of PBPC mobilization is still under investigation, it should be optimized for different tumor types to obtain antitumor effe

Beneficial impact of peripheral blood pr

Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor a randomized trial

✍ Alan Kritz; John P. Crown; Robert J. Motzer; Lilian M. Reich; Glenn Heller; Mich 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB